4.8 Article

TAZ, a transcriptional modulator of mesenchymal stem cell differentiation

Journal

SCIENCE
Volume 309, Issue 5737, Pages 1074-1078

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1110955

Keywords

-

Funding

  1. NCI NIH HHS [CA042063] Funding Source: Medline
  2. NIGMS NIH HHS [GM60594, GM68762] Funding Source: Medline

Ask authors/readers for more resources

Mesenchymal stem cells (MSCs) are a pluripotent cell type that can differentiate into several distinct lineages. Two key transcription factors, Runx2 and peroxisome proliferator-activated receptor gamma (PPAR gamma), drive MSCs to differentiate into either osteoblasts or adipocytes, respectively. How these two transcription factors are regulated in order to specify these alternate cell fates remains a pivotal question. Here we report that a 14-3-3-binding protein, TAZ (transcriptional coactivator with PDZ-binding motif), coactivates Runx2-dependent gene transcription white repressing PPAR gamma-dependent gene transcription. By modulating TAZ expression in model cell lines, mouse embryonic fibroblasts, and primary MSCs in culture and in zebrafish in vivo, we observed alterations in osteogenic versus adipogenic potential. These results indicate that TAZ functions as a molecular rheostat that modulates MSC differentiation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available